FibroGen, Inc.
FGEN
$0.2912
-$0.0269-8.46%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 131.98% | 73.14% | 82.27% | 57.07% | 15.03% |
| Total Depreciation and Amortization | -81.23% | -68.92% | -71.20% | -72.34% | -30.30% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -110.89% | 15.87% | -86.49% | -62.09% | -44.06% |
| Change in Net Operating Assets | -279.21% | 85.27% | 53.58% | 25.97% | 560.71% |
| Cash from Operations | -66.29% | 90.09% | 63.94% | 41.64% | 65.11% |
| Capital Expenditure | 43.82% | 88.01% | 98.59% | 95.09% | 24.62% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -84.20% | -100.00% | 618.00% | -50.70% | 634.80% |
| Cash from Investing | -83.18% | -98.61% | 605.70% | -50.45% | 837.05% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 92.59% | 27.27% | 96.61% | 93.02% | 74.65% |
| Issuance of Common Stock | -48.89% | -- | -99.43% | -- | -96.23% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Financing | 102.03% | -477.27% | -99.97% | -100.52% | -100.51% |
| Foreign Exchange rate Adjustments | -107.92% | -47.71% | 197.61% | 142.40% | -55.79% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -298.91% | 69.34% | 197.26% | -124.21% | -2,679.23% |